US2009022698A1PendingUtilityA1

Composition For Treatment Of Articular Cartilage Damage

Assignee: MEDIPOST CO LTDPriority: Aug 14, 2001Filed: Sep 24, 2008Published: Jan 22, 2009

Est. expiryAug 14, 2021(expired)· nominal 20-yr term from priority

Inventors:Chul Won Ha Yoon-Sun Yang Sung-Eun Yang

A61K 35/51A61P 19/00A61P 19/04A61K 35/28A61P 19/02A61K 35/14Y02A50/30

PatentIndex Score

Cited by

References

Claims

Abstract

Disclosed is a composition for the treatment of cartilage or bone damage or loss or defect. The composition comprises mesenchymal stem cells separated from umbilical cord blood and/or mesenchymal stem cells proliferated and/or differentiated. The composition also comprise chondrocytes and/or chondroblasts, or osteocytes and/or osteoblasts, differentiated from the mesenchymal stem cells separated from the umbilical cord blood.

Claims

exact text as granted — not AI-modified

1 - 14 . (canceled) 
   
   
       15 . A composition comprising chondrocytes and/or chondroblasts differentiated from mesenchymal stem cells, wherein the mesenchymal stem cells are isolated from umbilical cord blood. 
   
   
       16 . The composition according to  claim 15 , wherein the mesenchymal stem cells are further proliferated. 
   
   
       17 . The composition according to  claim 15 , which treats cartilage damage, loss, or defects when administered to a site of cartilage damage, loss, or defects in a subject. 
   
   
       18 . The composition according to  claim 15 , which is in an injectable formulation. 
   
   
       19 . The composition according to  claim 15 , wherein said composition contains 1×10 6  to 5×10 7  cells per mL of the composition.

Join the waitlist — get patent alerts

Track US2009022698A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.